doesn't always mean more

Recent, high-quality studies show that triclosan-coated sutures are not superior to non-triclosan-coated sutures in preventing surgical site infections (SSI).1 Make the switch to Medtronic.

Does plus equal more?
See for yourself.

Triclosan can be controversial.

GreenScreen™* hazard assessment ranks triclosan as a chemical of serious concern to be avoided.

  • Triclosan is considered an environmental toxicant.2
  • Triclosan is a weak agent against the bacteria linked to most SSI.2
  • Overuse of triclosan in a single patient could cause antimicrobial resistence.2

All of Medtronic's sutures are triclosan free.

New studies.
New standards.

  • The NIHR meta-analysis is the first study to use only high quality, unbiased trials.3
  • The FALCON study shows no evidence of difference in the risk of SSI with triclosan-coated sutures versus non-triclosan coated sutures.1
  • The financial burden associated with triclosan-coated sutures is significant.1

No clear benefit

The NIHR meta-analysis and FALCON studies discovered that triclosan-coated sutures show no superiority over non-triclosan-coated sutures in preventing SSI.1

Get in touch


Triclosan sutures surgeons study

NIHR meta-analysis FALCON summary

Triclosan sutures procurement study

Choose effective, innovative solutions.

From the game-changing V-Loc™ device family to absorbable sutures and beyond, learn more about our triclosan free sutures.


1. NIHR Global Research Health Unit on Global Surgery. Reducing surgical site infections in low-income and middle-income countries (FALCON): a pragmatic, multicentre, stratified, randomised controlled trial. The Lancet. 2021;398.

2. Khan R., Yee AL, Gilbert JA et al. Triclosan-containing sutures: safety and resistance issues need to be addressed prior to generalized use. Appl Nanosci. 2022;12: 3061–3070.

3. NIHR Global Research Health Unit on Global Surgery. Alcoholic chlorhexidine skin preparation or triclosan-coated sutures to reduce surgical site infection: a systematic review and meta-analysis of high-quality randomised controlled trials. The Lancet. May 2022.